Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer

Abstract Background Surgical resection of metastatic disease in patients with initially non-resectable colorectal cancer (CRC) has improved overall survival. Intensified chemotherapy regimens have increased the probability of converting unresectable metastasis to resectable. Here, we report the resu...

Full description

Bibliographic Details
Main Authors: Mahmoud A. Elshenawy, Ahmed Badran, Ali Aljubran, Ahmed Alzahrani, M. Shahzad Rauf, Abdelmoneim Eldali, Shouki Bazarbashi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:World Journal of Surgical Oncology
Subjects:
Colorectal cancer
Triplet chemotherapy
FOLFOXIRI-Bevacizumab
Surgery
Online Access:http://link.springer.com/article/10.1186/s12957-020-01930-8

Internet

http://link.springer.com/article/10.1186/s12957-020-01930-8

Similar Items